Published on the 2nd annual UN International Day to End Obstetric Fistula, this article features comments from Fistula Foundation CEO Kate Grant and Astellas Pharma Europe President & CEO Ken Jones on the new Action on Fistula program in Kenya. The story was also featured on Women’s News Network, The Guardian, and AllAfrica.
23 May 2014
NAIROBI (Thomson Reuters Foundation) — A “game changing” $2 million donation will help Kenyan surgeons to give 1,200 women life-transforming surgery to cure incontinence caused by fistula, a hole in the birth canal, and will train more specialists to perform the operation. […]
“This is the largest donation ever provided by any organisation or individual in the history of fistula,” said Kate Grant, chief executive officer of the Fistula Foundation, the recipient of the $2 million grant from Astellas, a Japanese pharmaceutical company.
“We’re thrilled with this partnership with Astellas and its potential to be a ‘game changer’ for fistula treatment. We hope to make Kenya, and what we are doing here, a model that we can take to other places.”
Read the full story here.